Darwin Wealth Management’s Gilead Sciences GILD Stock Holding History

Darwin Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.2K	Sell	216 -4	-2%	-$560	0.01%	266
2025 Q4	$27K	Sell	220 -24	-10%	-$2.92K	0.01%	273
2025 Q3	$27.1K	Buy	244 +31	+15%	+$3.52K	0.01%	266
2025 Q2	$23.6K	Buy	213 +3	+1%	+$319	0.01%	262
2025 Q1	$19.5K	Hold	210	–	–	0.01%	308
2024 Q4	$19.5K	Buy	210 +1	+0.5%	+$90	0.01%	308
2024 Q3	$17.6K	Buy	+209	New	+$15.9K	﹤0.01%	326
2020 Q3	–	Sell	-40,463	Closed	-$3.11M	–	163
2020 Q2	$3.11M	Buy	40,463 +39,951	+7,803%	+$3.06M	0.79%	43
2020 Q1	$38K	Buy	+512	New	+$35.4K	0.01%	273
2018 Q1	–	Sell	-24,163	Closed	-$1.73M	–	141
2017 Q4	$1.73M	Buy	+24,163	New	+$1.83M	0.74%	54

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Darwin Wealth Management's GILD Position: Q1 2026 in Review

Darwin Wealth Management reduced its Gilead Sciences (GILD) stake by 1.8% in Q1 2026, selling an estimated $560 and leaving 216 shares worth $30.2K. The position accounts for 0.01% of the portfolio, ranked #266.

Darwin Wealth Management first reported a position in GILD in Q4 2017 and has held it in 10 quarters since. The position peaked at $3.11M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Darwin Wealth Management held 216 shares of Gilead Sciences worth $30.2K as of Q1 2026.
Darwin Wealth Management sold 4 Gilead Sciences shares in Q1 2026, an estimated $560.
Gilead Sciences made up 0.01% of Darwin Wealth Management's portfolio in Q1 2026, its #266 holding.
Darwin Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 10 quarters since.
Darwin Wealth Management's Gilead Sciences position peaked at $3.11M in Q2 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Darwin Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.